Colin G. Sandercock's most recent trade in Cue Biopharma Inc was a trade of 200,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Apr 2026 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2025 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 175,000 | 175,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Colin G. Sandercock | SVP, GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 16,667 | 16,667 | - | - | Stock Option (right to buy) |